600812 华北制药
已收盘 12-31 15:00:00
资讯
新帖
简况
每周股票复盘：华北制药（600812）推“提质增效重回报”方案
证券之星 · 01-02 04:07
每周股票复盘：华北制药（600812）推“提质增效重回报”方案
华北制药（600812）披露“提质增效重回报”行动方案，12月29日股价下跌1.07%
证券之星 · 2025-12-29
华北制药（600812）披露“提质增效重回报”行动方案，12月29日股价下跌1.07%
华北制药（600812）披露为下属子公司提供担保的公告，12月2日股价上涨0.17%
证券之星 · 2025-12-02
华北制药（600812）披露为下属子公司提供担保的公告，12月2日股价上涨0.17%
每周股票复盘：华北制药（600812）完成5亿短期融资券兑付
证券之星 · 2025-11-23
每周股票复盘：华北制药（600812）完成5亿短期融资券兑付
华北制药（600812）披露召开2025年第三季度业绩说明会公告，11月19日股价下跌1.81%
证券之星 · 2025-11-19
华北制药（600812）披露召开2025年第三季度业绩说明会公告，11月19日股价下跌1.81%
每周股票复盘：华北制药（600812）子公司获原料药上市批准
证券之星 · 2025-11-09
每周股票复盘：华北制药（600812）子公司获原料药上市批准
华北制药（600812）披露下属公司获得《化学原料药上市申请批准通知书》，11月04日股价下跌0.65%
证券之星 · 2025-11-04
华北制药（600812）披露下属公司获得《化学原料药上市申请批准通知书》，11月04日股价下跌0.65%
华北制药(600812.SH)：头孢托仑匹酯化学原料药上市申请获批准
智通财经 · 2025-11-04
华北制药(600812.SH)：头孢托仑匹酯化学原料药上市申请获批准
华北制药（600812）2025年三季报简析：净利润同比增长54.69%，短期债务压力上升
证券之星 · 2025-10-26
华北制药（600812）2025年三季报简析：净利润同比增长54.69%，短期债务压力上升
华北制药（600812）披露2025年第三季度报告，10月24日股价下跌0.33%
证券之星 · 2025-10-24
华北制药（600812）披露2025年第三季度报告，10月24日股价下跌0.33%
每周股票复盘：华北制药（600812）董事会延期换届
证券之星 · 2025-10-12
每周股票复盘：华北制药（600812）董事会延期换届
华北制药（600812）披露关于董事会延期换届的提示性公告，10月10日股价上涨1.18%
证券之星 · 2025-10-10
华北制药（600812）披露关于董事会延期换届的提示性公告，10月10日股价上涨1.18%
每周股票复盘：华北制药（600812）子公司获注射用亚胺培南西司他丁钠药品注册证
证券之星 · 2025-09-21
每周股票复盘：华北制药（600812）子公司获注射用亚胺培南西司他丁钠药品注册证
华北制药最新公告：全资子公司获得注射用亚胺培南西司他丁钠药品注册证书
证券之星 · 2025-09-16
华北制药最新公告：全资子公司获得注射用亚胺培南西司他丁钠药品注册证书
每周股票复盘：华北制药（600812）获注射用万古霉素注册证
证券之星 · 2025-09-07
每周股票复盘：华北制药（600812）获注射用万古霉素注册证
华北制药(600812.SH)获得注射用盐酸万古霉素(0.5g)药品注册证书
智通财经 · 2025-09-02
华北制药(600812.SH)获得注射用盐酸万古霉素(0.5g)药品注册证书
每周股票复盘：华北制药（600812）股东户数减少，业绩显著提升
证券之星 · 2025-08-17
每周股票复盘：华北制药（600812）股东户数减少，业绩显著提升
华北制药（600812）2025年中报简析：营收净利润同比双双增长，短期债务压力上升
证券之星 · 2025-08-15
华北制药（600812）2025年中报简析：营收净利润同比双双增长，短期债务压力上升
华北制药(600812.SH)发布半年度业绩，归母净利润1.23亿元，同比增长71.56%
智通财经 · 2025-08-13
华北制药(600812.SH)发布半年度业绩，归母净利润1.23亿元，同比增长71.56%
肝素概念盘中跳水，常山药业跌0.39%
市场透视 · 2025-08-11
肝素概念盘中跳水，常山药业跌0.39%
加载更多
公司概况
公司名称：
华北制药股份有限公司
所属行业：
医药制造业
上市日期：
1994-01-14
主营业务：
华北制药股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是抗感染药物、防疫类药物、肾病及免疫调节剂、心脑血管类药物、维生素及健康消费品。公司曾先后获得国家发明奖5项、科技进步奖21项；被授予“中国医药行业功勋企业”和“中国制药大王”“全国医药行业药品质量诚信建设示范企业”等称号。
发行价格：
4.00
{"stockData":{"symbol":"600812","market":"SH","secType":"STK","nameCN":"华北制药","latestPrice":5.53,"timestamp":1767164400000,"preClose":5.53,"halted":0,"volume":6402450,"delay":0,"changeRate":0,"floatShares":1716000000,"shares":1716000000,"eps":0.1067,"marketStatus":"已收盘","change":0,"latestTime":"12-31 15:00:00","open":5.53,"high":5.55,"low":5.51,"amount":35419600,"amplitude":0.0072,"askPrice":5.54,"askSize":316,"bidPrice":5.53,"bidSize":2938,"shortable":0,"etf":0,"ttmEps":0.1067,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767576600000},"marketStatusCode":5,"adr":0,"adjPreClose":5.53,"symbolType":"stock","openAndCloseTimeList":[[1767144600000,1767151800000],[1767157200000,1767164400000]],"highLimit":6.08,"lowLimit":4.98,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1715730370,"isCdr":false,"pbRate":1.72,"roa":"--","peRate":51.827554,"roe":"2.898%","epsLYR":0.074,"committee":0.400985,"marketValue":9488000000,"turnoverRate":0.0037,"status":2,"floatMarketCap":9488000000},"requestUrl":"/m/hq/s/600812","defaultTab":"news","newsList":[{"id":"2600934039","title":"每周股票复盘：华北制药（600812）推“提质增效重回报”方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2600934039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600934039?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:07","pubTimestamp":1767298031,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，华北制药报收于5.62元，较上周的5.65元下跌0.53%。本周，华北制药12月23日盘中最高价报5.79元。本周关注点公司公告汇总：华北制药发布“提质增效重回报”行动方案，涵盖主业聚焦、股东回报等多项举措。华北制药发布“提质增效重回报”行动方案，内容包括聚焦主责主业、提升经营质量、重视股东回报、坚持科技创新、强化投资者关系管理、规范运作及治理水平提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600812","BK0191","BK0028"],"gpt_icon":0},{"id":"2595736575","title":"华北制药（600812）披露“提质增效重回报”行动方案，12月29日股价下跌1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595736575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595736575?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:42","pubTimestamp":1767019335,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，华北制药报收于5.56元，较前一交易日下跌1.07%，最新总市值为95.39亿元。近日，华北制药发布“提质增效重回报”行动方案。公司制定2023-2025年股东回报规划，近三年累计现金分红6,862.92万元，不低于年均净利润的30%。同日，公司发布的第十一届董事会第二十六次会议决议公告显示，会议审议通过《关于制定“提质增效重回报”行动方案的议案》，表决结果为同意10票，反对0票，弃权0票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900038196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0028","BK0239","600812"],"gpt_icon":0},{"id":"2588059098","title":"华北制药（600812）披露为下属子公司提供担保的公告，12月2日股价上涨0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588059098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588059098?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:27","pubTimestamp":1764685662,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，华北制药报收于5.87元，较前一交易日上涨0.17%，最新总市值为100.71亿元。公司近日发布公告称，华北制药股份有限公司为全资子公司华北制药集团先泰药业有限公司提供3,000万元连带责任保证担保，用于其项目贷款。本次担保在公司2024年年度股东大会审议通过的担保额度内，无需另行审议。截至公告日，公司为先泰公司实际担保余额为12,500万元。公司及控股子公司对外担保总额为153,913.06万元，占最近一期经审计净资产的28.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200039950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0191","BK0239","600812"],"gpt_icon":0},{"id":"2585010378","title":"每周股票复盘：华北制药（600812）完成5亿短期融资券兑付","url":"https://stock-news.laohu8.com/highlight/detail?id=2585010378","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585010378?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:02","pubTimestamp":1763838137,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，华北制药报收于5.71元，较上周的6.23元下跌8.35%。本周，华北制药11月17日盘中最高价报6.27元。公司公告汇总华北制药股份有限公司于2025年5月16日发行2025年度第一期短期融资券，发行总额为人民币5.00亿元，发行利率1.86%，期限180日，兑付日期为2025年11月15日。截至2025年11月17日，公司已完成本期短期融资券的兑付工作，本息兑付金额共计人民币504,586,301.37元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812","BK0239","BK0028","BK0191"],"gpt_icon":0},{"id":"2584947888","title":"华北制药（600812）披露召开2025年第三季度业绩说明会公告，11月19日股价下跌1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584947888","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584947888?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:20","pubTimestamp":1763562044,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，华北制药报收于5.96元，较前一交易日下跌1.81%，最新总市值为102.26亿元。公司近日发布公告称，华北制药股份有限公司将于2025年11月27日13:00-14:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会，介绍公司2025年第三季度经营成果及财务状况。投资者可于2025年11月20日至11月26日16:00前通过上证路演中心网站或公司邮箱提交问题，公司在说明会上将对普遍关注的问题进行回应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900039951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812","BK0191","BK0239","BK0028"],"gpt_icon":0},{"id":"2582864551","title":"每周股票复盘：华北制药（600812）子公司获原料药上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2582864551","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582864551?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:58","pubTimestamp":1762635490,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，华北制药报收于6.17元，较上周的6.0元上涨2.83%。本周，华北制药11月3日盘中最高价报6.2元。华北制药当前最新总市值105.86亿元，在化学制药板块市值排名51/151，在两市A股市值排名1803/5166。公司公告汇总华北制药全资子公司华北制药河北华民药业有限责任公司收到国家药监局签发的头孢托仑匹酯《化学原料药上市申请批准通知书》，批准其化学原料药上市。截至目前，国内共6家企业完成该原料药注册评审。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0191","600812"],"gpt_icon":0},{"id":"2580753150","title":"华北制药（600812）披露下属公司获得《化学原料药上市申请批准通知书》，11月04日股价下跌0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580753150","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580753150?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:45","pubTimestamp":1762267528,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘，华北制药报收于6.14元，较前一交易日下跌0.65%，最新总市值为105.35亿元。该股当日开盘6.16元，最高6.18元，最低6.1元，成交额达1.16亿元，换手率为1.1%。公司近日发布公告称，其全资子公司华北制药河北华民药业有限责任公司收到国家药品监督管理局签发的头孢托仑匹酯《化学原料药上市申请批准通知书》，批准其化学原料药上市申请。截至目前，国内共有6家企业完成该原料药注册评审。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400039784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","600812","BK0028"],"gpt_icon":0},{"id":"2580783666","title":"华北制药(600812.SH)：头孢托仑匹酯化学原料药上市申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2580783666","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580783666?lang=zh_cn&edition=full","pubTime":"2025-11-04 16:49","pubTimestamp":1762246149,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华北制药 公告，公司全资子公司华北制药河北华民药业有限责任公司收到国家药品监督管理局核准签发的头孢托仑匹酯《化学原料药上市申请批准通知书》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365029.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0191","BK0028","600812","BK0239"],"gpt_icon":0},{"id":"2578683302","title":"华北制药（600812）2025年三季报简析：净利润同比增长54.69%，短期债务压力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2578683302","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578683302?lang=zh_cn&edition=full","pubTime":"2025-10-26 06:02","pubTimestamp":1761429771,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华北制药发布2025年三季报。截至本报告期末，公司营业总收入74.85亿元，同比下降1.0%，归母净利润1.59亿元，同比上升54.69%。按单季度数据看，第三季度营业总收入22.1亿元，同比下降5.12%，第三季度归母净利润3500.66万元，同比上升14.85%。本报告期华北制药短期债务压力上升，流动比率达0.67。去年的净利率为2.18%，算上全部成本后，公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812"],"gpt_icon":0},{"id":"2577517031","title":"华北制药（600812）披露2025年第三季度报告，10月24日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577517031","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577517031?lang=zh_cn&edition=full","pubTime":"2025-10-24 22:26","pubTimestamp":1761315979,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，华北制药报收于6.08元，较前一交易日下跌0.33%，最新总市值为104.32亿元。该股当日开盘6.12元，最高6.12元，最低6.04元，成交额达1.15亿元，换手率为1.11%。近日，华北制药发布2025年第三季度报告，披露了公司前三季度的经营数据。根据公告，2025年前三季度，公司实现营业收入7,484,828,636.64元，同比下降1.00%；归属于上市公司股东的净利润为158,504,018.75元，同比增长54.69%；扣除非经常性损益后的净利润为143,324,253.00元，同比增长73.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400042899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812","BK0239","BK0028","BK0191"],"gpt_icon":0},{"id":"2574468482","title":"每周股票复盘：华北制药（600812）董事会延期换届","url":"https://stock-news.laohu8.com/highlight/detail?id=2574468482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574468482?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:27","pubTimestamp":1760210832,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，华北制药报收于6.01元，较上周的5.85元上涨2.74%。本周，华北制药10月10日盘中最高价报6.02元。华北制药当前最新总市值103.12亿元，在化学制药板块市值排名51/150，在两市A股市值排名1830/5158。本周关注点公司公告汇总：华北制药董事会换届延期，现任成员继续履职至换届完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0191","600812"],"gpt_icon":0},{"id":"2574778177","title":"华北制药（600812）披露关于董事会延期换届的提示性公告，10月10日股价上涨1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574778177","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574778177?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:50","pubTimestamp":1760107829,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，华北制药报收于6.01元，较前一交易日上涨1.18%，最新总市值为103.12亿元。该股当日开盘5.95元，最高6.02元，最低5.92元，成交额达1.39亿元，换手率为1.35%。公司近日发布公告称，第十一届董事会、监事会将于2025年10月11日任期届满。公司将积极推进董事会换届及监事会改革等工作进程，并及时履行信息披露义务。董事会延期换届不会影响公司正常运营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000039797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812","BK0028","BK0239","BK0191"],"gpt_icon":0},{"id":"2569701245","title":"每周股票复盘：华北制药（600812）子公司获注射用亚胺培南西司他丁钠药品注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2569701245","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569701245?lang=zh_cn&edition=full","pubTime":"2025-09-21 03:44","pubTimestamp":1758397454,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，华北制药报收于5.92元，较上周的6.03元下跌1.82%。本周，华北制药9月18日盘中最高价报6.07元。本周关注点公司公告汇总：全资子公司深圳华药南方制药获注射用亚胺培南西司他丁钠《药品注册证书》，视为通过仿制药一致性评价。公司公告汇总华北制药全资子公司深圳华药南方制药有限公司收到国家药监局核准签发的注射用亚胺培南西司他丁钠《药品注册证书》，批准文号为国药准字H20255370，有效期至2030年9月8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0191","600812"],"gpt_icon":0},{"id":"2567032381","title":"华北制药最新公告：全资子公司获得注射用亚胺培南西司他丁钠药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2567032381","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567032381?lang=zh_cn&edition=full","pubTime":"2025-09-16 17:27","pubTimestamp":1758014876,"startTime":"0","endTime":"0","summary":"华北制药(600812.SH)公告称，公司全资子公司深圳华药南方制药有限公司收到国家药品监督管理局核准签发的注射用亚胺培南西司他丁钠（1.0g）《药品注册证书》。该药品适用于由敏感细菌所引起的多种感染，包括腹腔内感染、下呼吸道感染等。截至目前，国内共有10家企业持有该药品的药品注册证书。该药品2024年国内市场销售额达23亿元。南方公司获得该证书，完善了其抗感染领域的产品结构，但制剂产品销售业务仍受行业政策、市场环境等因素影响，存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600027790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0191","600812","BK0239"],"gpt_icon":0},{"id":"2565456305","title":"每周股票复盘：华北制药（600812）获注射用万古霉素注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2565456305","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565456305?lang=zh_cn&edition=full","pubTime":"2025-09-07 06:09","pubTimestamp":1757196551,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，华北制药报收于6.18元，较上周的6.33元下跌2.37%。本周，华北制药9月1日盘中最高价报6.37元。本周关注点公司公告汇总：华北制药获注射用盐酸万古霉素《药品注册证书》。华北制药收到国家药监局核准签发的注射用盐酸万古霉素《药品注册证书》，药品注册标准编号YBH19752025，药品批准文号国药准字H20255230，有效期至2030年8月25日。截至目前，国内共有9家企业持有该规格药品注册证书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0191","BK0239","600812"],"gpt_icon":0},{"id":"2564380532","title":"华北制药(600812.SH)获得注射用盐酸万古霉素(0.5g)药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2564380532","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564380532?lang=zh_cn&edition=full","pubTime":"2025-09-02 18:17","pubTimestamp":1756808247,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华北制药(600812.SH)发布公告，近日，公司收到国家药品监督管理局核准签发的注射用盐酸万古霉素(0.5g)《药品注册证书》。此次公司获得注射用盐酸万古霉素(0.5g)《药品注册证书》，证明该产品具备了集采招标基本准入条件，产品药效等同于原研产品，在公司已有产品万迅(注射用盐酸去甲万古霉素)的基础上，有效完善了抗感染领域的产品结构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1340600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华北制药(600812.SH)获得注射用盐酸万古霉素(0.5g)药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0239","BK0191","600812"],"gpt_icon":0},{"id":"2560925054","title":"每周股票复盘：华北制药（600812）股东户数减少，业绩显著提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2560925054","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560925054?lang=zh_cn&edition=full","pubTime":"2025-08-17 04:30","pubTimestamp":1755376229,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘，华北制药报收于6.63元，较上周的6.63元上涨0.0%。本周，华北制药8月13日盘中最高价报7.12元。华北制药当前最新总市值113.75亿元，在化学制药板块市值排名51/150，在两市A股市值排名1629/5152。关于冀中能源集团财务有限责任公司的风险持续评估报告显示，财务公司成立于1993年，注册资本截至2025年5月为55亿元。各项监管指标均符合规定，整体风险可控。华北制药在财务公司的存款安全性和流动性良好，未影响公司正常生产经营。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600812","BK0191","BK0239"],"gpt_icon":0},{"id":"2559967111","title":"华北制药（600812）2025年中报简析：营收净利润同比双双增长，短期债务压力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2559967111","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559967111?lang=zh_cn&edition=full","pubTime":"2025-08-15 06:02","pubTimestamp":1755208946,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华北制药发布2025年中报。截至本报告期末，公司营业总收入52.75亿元，同比上升0.84%，归母净利润1.23亿元，同比上升71.56%。按单季度数据看，第二季度营业总收入27.01亿元，同比上升1.02%，第二季度归母净利润6600.58万元，同比上升22.61%。本报告期华北制药短期债务压力上升，流动比率达0.71。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081500004962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600812"],"gpt_icon":0},{"id":"2559461601","title":"华北制药(600812.SH)发布半年度业绩，归母净利润1.23亿元，同比增长71.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559461601","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559461601?lang=zh_cn&edition=full","pubTime":"2025-08-13 19:38","pubTimestamp":1755085112,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华北制药 披露2025年半年度报告，报告期公司实现营收52.75亿元，同比增长0.84%;归属于上市公司股东的净利润1.23亿元，同比增长71.56%;扣非净利润1.2亿元，同比增长120.69%;基本每股收益0.072元。归属于上市公司股东的扣除非经常性损益的净利润增加，扣除非经常性损益后的基本每股收益增加，主要是公司净利润增加的同时非经常性损益较上年同期大幅减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"华北制药(600812.SH)发布半年度业绩，归母净利润1.23亿元，同比增长71.56%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600812"],"gpt_icon":0},{"id":"2558675680","title":"肝素概念盘中跳水，常山药业跌0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558675680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558675680?lang=zh_cn&edition=full","pubTime":"2025-08-11 09:37","pubTimestamp":1754876273,"startTime":"0","endTime":"0","summary":"08月11日，肝素概念盘中跳水，截至09点37分，肝素概念整体指数下跌0.53%，报1134.390点。从个股上来看，该概念的成分股中，常山药业跌0.39%，双鹭药业、华北制药、复星医药跌幅居前。从资金上来看，截止发稿，肝素概念主力净流入为-1878.77万，其中辰欣药业受到资金热捧，主力净流入2096.65万；拉长时间线来看，该板块近20日主力资金净流入-34.44亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081109375394dbbc6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081109375394dbbc6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0012","BK0172","600196","BK0060","02196","BK0028","BK0175","BK0183","BK0070","603367","BK0196","600812","300255","BK0188","BK0096","BK0187"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767553635058,"stockEarnings":[{"period":"1week","weight":-0.0178},{"period":"1month","weight":-0.0563},{"period":"3month","weight":-0.0547},{"period":"6month","weight":-0.1389},{"period":"1year","weight":0.0744},{"period":"ytd","weight":0.0744}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.014},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.143},{"period":"1year","weight":0.1841},{"period":"ytd","weight":0.1841}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华北制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"88011人(较上一季度增加4.79%)","perCapita":"19494股","listingDate":"1994-01-14","address":"河北省石家庄市长安区和平东路388号","registeredCapital":"171573万元","survey":" 华北制药股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是抗感染药物、防疫类药物、肾病及免疫调节剂、心脑血管类药物、维生素及健康消费品。公司曾先后获得国家发明奖5项、科技进步奖21项；被授予“中国医药行业功勋企业”和“中国制药大王”“全国医药行业药品质量诚信建设示范企业”等称号。","listedPrice":4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华北制药(600812)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华北制药(600812)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华北制药,600812,华北制药股票,华北制药股票老虎,华北制药股票老虎国际,华北制药行情,华北制药股票行情,华北制药股价,华北制药股市,华北制药股票价格,华北制药股票交易,华北制药股票购买,华北制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华北制药(600812)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华北制药(600812)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}